Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert P Anderson

Showing results (41-50 of 69) with videos related to

Pageof 7
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|March 21, 2009
Intestinal T cell responses to gluten peptides are largely heterogeneous: implications for a peptide-based therapy in celiac diseaseAlessandra Camarca, Robert P Anderson, Gianfranco Mamone, et al.
Clinical & Translational Immunology|January 21, 2020
Circulating gluten-specific, but not CMV-specific, CD39<sup>+</sup> regulatory T cells have an oligoclonal TCR repertoireLaura Cook, C Mee Ling Munier, Nabila Seddiki, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 5, 2009
Resistance to celiac disease in humanized HLA-DR3-DQ2-transgenic mice expressing specific anti-gliadin CD4+ T cellsAndrea L de Kauwe, Zhenjun Chen, Robert P Anderson, et al.
Scientific Reports|December 23, 2017
Deep sequencing of blood and gut T-cell receptor β-chains reveals gluten-induced immune signatures in celiac diseaseDawit A Yohannes, Tobias L Freitag, Andrea de Kauwe, et al.
Alimentary Pharmacology & Therapeutics|November 27, 2019
Masked bolus gluten challenge low in FODMAPs implicates nausea and vomiting as key symptoms associated with immune activation in treated coeliac diseaseA James M Daveson, Jason A Tye-Din, Gautam Goel, et al.
BMC Medicine|November 26, 2020
Patient factors influencing acute gluten reactions and cytokine release in treated coeliac diseaseJason A Tye-Din, A James M Daveson, Kaela E Goldstein, et al.
Gastroenterology|June 11, 2025
Blood-based T Cell Diagnosis of Celiac DiseaseOlivia G Moscatelli, Amy K Russell, Lee M Henneken, et al.
Plos One|September 28, 2011
Suppression of inflammatory immune responses in celiac disease by experimental hookworm infectionHenry J McSorley, Soraya Gaze, James Daveson, et al.
Gastroenterology|March 28, 2026
A Randomized Double-Blind, Placebo-Controlled Dose-Response Study to Assess the Gluten Threshold Dose in Celiac DiseaseA James M Daveson, Emma Craig, Alina Vitak, et al.
Ebiomedicine|December 2, 2017
Epitope-Specific Immunotherapy Targeting CD4-Positive T Cells in Celiac Disease: Safety, Pharmacokinetics, and Effects on Intestinal Histology and Plasma Cytokines with Escalating Dose Regimens of Nexvax2 in a Randomized, Double-Blind, Placebo-Controlled Phase 1 StudyA James M Daveson, Hooi C Ee, Jane M Andrews, et al.
Pageof 7

Showing results (41-50 of 69) with videos related to

Sort By:
Pageof 7
Journal of Immunology (Baltimore, Md. : 1950)|March 21, 2009
Intestinal T cell responses to gluten peptides are largely heterogeneous: implications for a peptide-based therapy in celiac diseaseAlessandra Camarca, Robert P Anderson, Gianfranco Mamone, et al.
Clinical & Translational Immunology|January 21, 2020
Circulating gluten-specific, but not CMV-specific, CD39<sup>+</sup> regulatory T cells have an oligoclonal TCR repertoireLaura Cook, C Mee Ling Munier, Nabila Seddiki, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 5, 2009
Resistance to celiac disease in humanized HLA-DR3-DQ2-transgenic mice expressing specific anti-gliadin CD4+ T cellsAndrea L de Kauwe, Zhenjun Chen, Robert P Anderson, et al.
Scientific Reports|December 23, 2017
Deep sequencing of blood and gut T-cell receptor β-chains reveals gluten-induced immune signatures in celiac diseaseDawit A Yohannes, Tobias L Freitag, Andrea de Kauwe, et al.
Alimentary Pharmacology & Therapeutics|November 27, 2019
Masked bolus gluten challenge low in FODMAPs implicates nausea and vomiting as key symptoms associated with immune activation in treated coeliac diseaseA James M Daveson, Jason A Tye-Din, Gautam Goel, et al.
BMC Medicine|November 26, 2020
Patient factors influencing acute gluten reactions and cytokine release in treated coeliac diseaseJason A Tye-Din, A James M Daveson, Kaela E Goldstein, et al.
Gastroenterology|June 11, 2025
Blood-based T Cell Diagnosis of Celiac DiseaseOlivia G Moscatelli, Amy K Russell, Lee M Henneken, et al.
Plos One|September 28, 2011
Suppression of inflammatory immune responses in celiac disease by experimental hookworm infectionHenry J McSorley, Soraya Gaze, James Daveson, et al.
Gastroenterology|March 28, 2026
A Randomized Double-Blind, Placebo-Controlled Dose-Response Study to Assess the Gluten Threshold Dose in Celiac DiseaseA James M Daveson, Emma Craig, Alina Vitak, et al.
Ebiomedicine|December 2, 2017
Epitope-Specific Immunotherapy Targeting CD4-Positive T Cells in Celiac Disease: Safety, Pharmacokinetics, and Effects on Intestinal Histology and Plasma Cytokines with Escalating Dose Regimens of Nexvax2 in a Randomized, Double-Blind, Placebo-Controlled Phase 1 StudyA James M Daveson, Hooi C Ee, Jane M Andrews, et al.
Pageof 7